Worldwide has managed 300+ clinical trials using the cloud-based clinical trial-management software, IBM® Clinical Development. Learn more about how this technology improves clinical trial efficiency with this IBM case study.
As a full-service CRO, we have an outstanding track record in starting up and executing MS studies, including beta-interferons, glatiramer acetate monoclonal antibodies, and oral preparations for disease-modifying approaches.
In this case study, learn how Worldwide Clinical Trials helped GeNeuro address their key study challenges.
Worldwide Clinical Trials was retained to intervene in a Phase IIb, multinational, randomized, double-blind, placebo-controlled study in subjects with progressive cognitive decline compatible with the diagnosis of prodromal Alzheimer’s disease (AD) and we’ve provided a working and significant outcome.